Faculty

Jonathan M. Meyer, MD

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
Distinguished Life Fellow
American Psychiatric Association
San Diego, California

Lynn Marie Trotti, MD, MSc

Associate Professor of Neurology
Emory University School of Medicine
Emory Healthcare

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Stephen R. Saklad, PharmD, BCPP

Emeritus Clinical Professor
The University of Texas at Austin
College of Pharmacy
Division of Pharmacotherapy
UT Health San Antonio
School of Medicine
San Antonio, Texas

Steven C. Stoner, PharmD, BCPP

Clinical Professor
Psychiatric Pharmacy Specialist
Associate Dean for Student Affairs
UMKC School of Pharmacy
Kansas City, Missouri

Lisa Harding, MD

Medical Director of Depression MD
Assistant Clinical Professor of Psychiatry
Yale School Of Medicine
New Haven, Connecticut

Michael Alpert, MD

Sub-investigator, Educator, Psychiatrist
MAPS Public Benefit Corporation
Instructor
Department of Psychiatry
Beth Israel Deaconess Medical Center – Harvard Medical School
Boston, Massachusetts

Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
New York, New York
Professor and Chair
Department of Child and Adolescent Psychiatry
Charité University Medicine
Berlin, Germany

Samantha Catanzano, PharmD, BCPP

Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Psychiatric Pharmacist
UT Health Austin, Dell Medical School
Austin, Texas

Michael Sprintz, DO, DFASAM

Medical Consultant
Chronic Pain, Addiction, Healthcare Technology
Founder, Sprintz Center for Recovery
The Woodlands, Texas

Austin Campbell, PharmD, BCCP

Clinical Assistant Professor
UMKC School of Pharmacy at MU
Adjunct Assistant Professor
University of Missouri School of Medicine
Columbia, Missouri

Andrew Cutler, MD

Chief Medical Officer
Neuroscience Education Institute
Carlsbad, CA
Clinical Associate Professor of Psychiatry
SUNY Upstate Medical University
Syracuse, New York

Gustavo Alva, MD

Medical Director
ATP Clinical Research
Assistant Professor
Department of Psychiatry and Neuroscience
Unviersity of California, Riverside
Private Practice Psychiatrist
Pacific Neuropsychiatric Specialists
Costa Mesa, California

Brittany Albright, MD, MPH

Chief Executive Officer and Medical Director
Sweetgrass Psychiatry, LLC
Mount Pleasant, SC

Chet Robachinski, MD

Psychiatric Director
Bailey-Boushay House
Founding Partner and Psychiatrist
Associates in Behavioral Health P.L.L.C
Seattle, Washington

Agenda
Location
CME/CE Info
Accreditation
Acknowledgement

Agenda

Friday, December 8, 2023—Eastern Time Zone

7:00 AM – 8:00 AM Registration and Breakfast/Coffee Talk With Key Opinion Leaders

In-person learners are invited to start off the morning with key opinion leaders as well as other colleagues to enjoy coffee and informal discussions about hot topics related to the pharmacotherapy of psychiatric illness.

8:00 AM – 8:10 AM Opening Remarks by Moderator Jonathan M. Meyer, MD

8:10 AM – 9:10 AM CME Session 1—Debate: New vs Old Mechanisms of Action in the Treatment of Psychotic Disorders – Presented by: Jonathan M. Meyer, MD, and Christoph U. Correll, MD; moderated by Stephen R. Saklad, PharmD, BCPP

Join us for an exciting debate focusing on the efficacy, safety, and clinical role of emerging non-D2–blocking medications vs traditional D2-blocking antipsychotic agents in treating patients with major depressive disorder.

9:10 AM – 9:20 AM Break

9:20 AM – 10:20 AM Non-CME Educational Session: Sponsored by Intra-Cellular Therapies, Inc. — Clinical Perspectives on a Treatment Option for Bipolar Depression (Bipolar I and II) – Presented by: Andrew J. Cutler, MD

Bipolar depression can be debilitating to patients, and difficulties in appropriate diagnosis and comorbidities can add to the challenge. This presentation will explore these challenges, as well as a treatment option approved for BOTH bipolar I and bipolar II depression in adults.

10:20 AM – 10:30 AM Break

10:30 AM – 11:30 AM CME Session 2—Addressing the Complexities of Tardive Dyskinesia Treatment in Older Adults: A Pharmacologic Perspective – Presented by: Steven C. Stoner, PharmD, BCPP

This session will explore the pharmacologic treatment of TD, the pharmacokinetics and pharmacodynamics of VMAT2 inhibitors, and considerations for dosing and titration in aging and other special populations.

11:30 AM – 11:35 AM Wellness Break

11:35 AM – 12:35 PM CME Session 3—Advances in Narcolepsy Treatment – Presented by: Lynn Trotti, MD, MSc

The focus of this session will be on treatment advances in narcolepsy, including the pharmacology of new and emerging medications and formulations.

12:35 PM – 1:05 PM Virtual Poster Hall Viewing and Lunch

1:05 PM – 2:05 PM Non-CME Educational Session: Sponsored by Acadia Pharmaceuticals, Inc. — A Focused Approach to the Management of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis – Presented by: Gustavo Alva, MD, DFAPA

Dr. Alva will discuss educational information about hallucinations and delusions associated with Parkinson’s disease (PD) psychosis, including the symptoms of PD psychosis, a non-motor aspect of PD, and how they progress over time; the impact and burden of PD psychosis on patients, their caregivers, and society; and the relevant treatment considerations when addressing PD psychosis. Dr. Alva will also review clinical efficacy for a treatment option and real-world evidence from retrospective analyses investigating the risk of all-cause mortality among patients with PD psychosis treated with atypical antipsychotics.

2:05 PM – 2:15 PM Break

2:15 PM – 3:15 PM CME Session 4—Augmentation in MDD: Using Pharmacology to Guide Treatment – Presented by: Lisa Harding, MD

Medication characteristics can help determine the appropriate medication for augmentation in a patient with MDD. This session will focus on differentiation of the augmentation options based on adverse event profile, pharmacokinetics, dosing frequency, and others to use pharmacology to guide treatment for patients with MDD demonstrated through patient cases.

3:15 PM – 3:20 PM Wellness Break

3:20 PM – 4:20 PM CME Session 5—The Psychopharmacology of Psychedelics – Presented by: Michael Alpert, MD

Psychedelic-assisted therapy is emerging in the treatment of psychiatric disorders like MDD and PTSD. This session will focus on the psychopharmacology of emerging psychedelics, including mechanisms of action, efficacy and safety data, and monitoring best practices.

4:20 PM – 4:30 PM Closing Remarks by Moderator Jonathan M. Meyer, MD

4:30 PM – 5:30 PM Welcome Reception

In-person learners are invited to join us at the welcome reception Friday evening after the first day of the conference. Connect with familiar colleagues, network with new faces, and spark meaningful conversation over food, music, and fun in this atmosphere of intellectual curiosity!

Saturday, December 9, 2023—Eastern Time Zone

7:00 AM – 8:00 AM Registration and Breakfast/Coffee Talk With Key Opinion Leaders

In-person learners are invited to start off the morning with key opinion leaders as well as other colleagues to enjoy coffee and informal discussions about hot topics related to the pharmacotherapy of psychiatric illness.

8:00 AM – 8:10 AM Opening Remarks by Moderator Joseph F. Goldberg, MD

8:10 AM – 9:10 AM CME Session 6—Treatment of Bipolar Depression: Pharmacology-Based Individualization – Presented by: Joseph F. Goldberg, MD

This session will focus on the pharmacotherapy of bipolar depression, including the evidence for antidepressant use in bipolar disorder and differentiation of treatment options for bipolar depression with and without mixed features based on medication characteristics like receptor binding profile, adverse effects, and pharmacokinetics.

9:10 AM – 9:20 AM Break

9:20 AM – 10:20 AM Non-CME Educational Session: Sponsored by Janssen Pharmaceuticals, Inc. — An Established Therapy for Treatment-resistant Depression (TRD) in Adults – Presented by: Brittany Albright, MD, MPH and Chet Robachinski, MD

10:20 AM – 10:30 AM Break

10:30 AM – 11:45 AM CME Session 7—Opioid REMS Workshop: Applying Best Practices in Pain Management: Delivering Holistic Patient-Centered Care to Minimize Health Disparities and Adverse Opioid Outcomes – Presented by: Samantha Catanzano, PharmD, BCPP, and Michael Sprintz, DO, DFASAM

This Opioid REMS workshop aligns with all elements of the revised FDA Blueprint and addresses topics including pain assessment and management, risk assessment and treatment for substance use disorders, and mechanisms of action for medications used to treat pain and opioid use disorder.

11:45 AM – 12:15 PM Lunch Break

12:15 PM – 1:30 PM CME Session 7 (cont’d)—Opioid REMS Workshop: Applying Best Practices in Pain Management: Delivering Holistic Patient-Centered Care to Minimize Health Disparities and Adverse Opioid Outcomes – Presented by: Samantha Catanzano, PharmD, BCPP, and Michael Sprintz, DO, DFASAM

This Opioid REMS workshop aligns with all elements of the revised FDA Blueprint and addresses topics including pain assessment and management, risk assessment and treatment for substance use disorders, and mechanisms of action for medications used to treat pain and opioid use disorder.

1:30 PM – 1:40 PM Wellness Break

1:40 PM – 2:40 PM CME Session 8—Moving Targets: Novel Mechanisms for the Treatment of MDD – Presented by: Stephen R. Saklad, PharmD, BCPP

This session will focus on new and emerging medications with novel mechanisms of action, including how the new mechanisms affect the pathophysiology of MDD, the latest clinical evidence, and how to integrate these options into the treatment algorithm. Patient case discussions will be used to demonstrate patient care plans using new treatment options for MDD.

2:40 PM – 2:50 PM Wellness Break

2:50 PM – 3:50 PM CME Session 9—Navigating the Complexities of Schizophrenia Treatment: From Challenges to Tailored Solutions – Presented by: Austin Campbell, PharmD, BCPP

Achieving treatment adherence in patients with schizophrenia often includes many challenges. This session will focus on the unmet needs, patient adherence, and treatment options in schizophrenia. Through patient case discussions, the role of emerging agents, long-acting injectable antipsychotics, and gold-standard treatment options will also be discussed.

3:50 PM – 4:00 PM Closing Remarks by Moderator Joseph F. Goldberg, MD

Location

Venue Name

JW Marriott Orlando Grande Lakes

Address

JW Marriott Orlando Grande Lakes
4040 Central Florida Parkway
Orlando, Florida 32837

Room Name

Mediterranean 1-3 & 4

Event Manager Info

Hotel Room Block: https://book.passkey.com/go/PsychopharmacologyUpdate2023

The last day to reserve a room at the group rate will be November 24, 2023.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess optimal medication use and new and emerging therapies for the treatment of psychiatric illness.

Target Audience
This activity is intended for physicians, physician assistants/physician associates, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

Discuss the latest advances in the pharmacologic management of psychiatric disorders.
Implement evidence-based pharmacotherapy for treatment of psychiatric disorders.
Individualize treatment choices for psychiatric disorders based on efficacy, safety, and patient characteristics.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 10.5 contact hours, including 10.5 hours of pharmacology credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 10.5 contact hours (1.05 CEUs) of the Accreditation Council for Pharmacy Education. UAN: UAN will be specific to each topic

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 10.5 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 10.5 clinical continuing education credits.

*ADA CERP and COPE credit for the Opioid REMS Workshop only

Dental Professionals Continuing Education
Clinical Care Options, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Clinical Care Options, LLC designates this activity for 2.5 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Optometrist Continuing Education
Clinical Care Options, LLC designates this synchronous in-person (synchronous virtual, asynchronous enduring, etc.) activity for a maximum of 2.5 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from AbbVie Inc.; Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc; and Opioid Analgesic REMS Program Companies.

Clinical Education Alliance Terms and Conditions

These Terms of Use ("Terms") apply to your use of the websites, mobile applications and other resources provided by Clinical Education Alliance LLC (“CEA”) and its affiliates (referred to collectively as "CEA," "us," "we" and "our") that are intended for use by healthcare professionals, which we refer to as the "CEA Network," including the personalized information and services that meet the needs and interests of users of the CEA Network such as medical news, reference content, clinical tools, applications, sponsored programs, advertising, email communications, continuing medical education, market research opportunities and discussion forums (collectively, the "Services"). You will always be able to view the most current version of these Terms by clicking on the Terms of Use link at the bottom of any page of a CEA Network property. Note that these Terms do not apply to our properties and services that display a link to different terms of use. In the event that we expand the CEA Network through our acquisition of another company and/or its properties, that company may operate its properties subject to its own terms of use accessible via a link on such properties until we integrate its practices with ours, at which point a link to these Terms will be displayed on its properties. By using the Services, you agree to these Terms, whether or not you are a registered member of the CEA Network. These Terms govern your use of the Services and create a binding legal agreement that we may enforce against you in the event of a violation. If you do not agree to all of these Terms of Use, do not use the Services!

We reserve the right to change these terms from time to time. The most current version may be viewed by clicking on the “Terms of Use” link at the bottom of designated pages on the Clinical Education Alliance Sites. Use of the Clinical Education Alliance Sites after the effective date constitutes acceptance of the amended Terms of Use. When you leave a CEA Web site and go to another Web site, different terms apply and CEA has no responsibility or liability for any content on those sites.

Clinical Education Alliance Content

The Clinical Education Alliance Sites incorporate information, including modules, capsules, journal articles, medical news, references, interactive case studies, other continuing education material, downloadable software applications, advertising, and other healthcare information, which is intended for adults who are licensed healthcare professionals. This information is not intended to serve as a substitute for the healthcare professional’s clinical judgment. If you are a consumer who chooses to read this professional-level information on Clinical Education Alliance Sites, you should not use or rely on that information as professional medical advice or use it to replace any relationship with your physician or other qualified healthcare professional or any information they may have provided to you. For medical issues or concerns, including decisions about medications and other treatments, consumers should always consult their physician or, in serious cases, seek immediate assistance from emergency personnel.

The Content on the Clinical Education Alliance Sites is developed or selected in accordance with our published Editorial Policies. However, users access and use this material at their own risk. It is the reader’s job to evaluate the accuracy of any information and results from interactive programs found on the Clinical Education Alliance Site. If you are a healthcare professional, you should rely on your professional judgment in evaluating any and all information and confirm the information contained on the Clinical Education Alliance Sites with other sources and reliable third parties before basing any treatment or advice on it. If you are a consumer, you should evaluate the information together with your physician or another qualified healthcare professional.

DISCLAIMERS AND LIMITATIONS OF LIABILITY

THE CONTENT, APPLICATIONS, SOFTWARE, AND ALL OTHER MATERIAL ON THE CLINICAL EDUCATION ALLIANCE SITES ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. ALL WARRANTIES, EXPRESS OR IMPLIED, ARE HEREBY DISCLAIMED. CLINICAL EDUCATION ALLIANCE SHALL NOT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, PHYSICAL HARM OR INJURIES, LOST REVENUES, OR LOST PROFITS, RESULTING FROM THE USE OR MISUSE OF THE CLINICAL EDUCATION ALLIANCE SITES, OR ANY INFORMATION, APPLICATIONS, MATERIALS, OR SOFTWARE THEREON, EVEN IF CLINICAL EDUCATION ALLIANCE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, OR FOR ANY CLAIM BY ANOTHER PARTY. CLINICAL EDUCATION ALLIANCE DOES NOT WARRANT THAT THIS SITE OR ANY APPLICATIONS OR SOFTWARE WILL BE FREE OF BUGS, INACCURACIES, OR ERRORS, NOR DOES CLINICAL EDUCATION ALLIANCE WARRANT THAT ANY SITE, SOFTWARE, OR APPLICATION IS FREE OF VIRUSES OR OTHER HARMFUL ELEMENTS.

A user’s use of the Clinical Education Alliance Sites, and any reliance on any materials, information, software, or applications, is at the user’s own risk. You agree that you hereby release Clinical Education Alliance and its affiliates, owners, respective directors, officers, employees, advertisers, authors, and contributors from any and all liability or obligations arising from the use of the Clinical Education Alliance Sites. A user’s sole remedy for any problem or concern is to exit the Web site or application. You agree that you will indemnify and hold Clinical Education Alliance harmless for any loss, damages, or liability suffered by Clinical Education Alliance as a result of your use of any Clinical Education Alliance Site or material, application, information, or software thereon or your submission of any material to Clinical Education Alliance. Clinical Education Alliance reserves the right to restrict or limit access to this Web site.

CEA Programs, Tools, and Databases

The Clinical Education Alliance Sites include interactive programs, clinical tools, and databases intended for the use of healthcare professionals. These materials are not intended as professional advice or recommendations of particular products. Physicians and other healthcare professionals who use our interactive programs, tools, or databases should exercise their own clinical judgment as to the results. Consumers who use the tools or databases do so at their own risk.

Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. For medical concerns or issues, including decisions about medications and other treatments, users should always consult their physician or other qualified healthcare professional.

Ownership of Clinical Education Alliance Sites—Copyright and Trademarks

The entire contents and design of the Clinical Education Alliance Sites, including the software applications, tools, and databases, are protected under US and international copyright laws. These materials are owned by CEA or its affiliates or are used with permission of their owners or as otherwise authorized by law. All rights are reserved, worldwide. You may look at the Clinical Education Alliance Sites, download individual articles or applications to your personal computer or handheld device, and print a reasonable number of pages for your own personal reference. You must not remove any copyright notices from our materials. We reserve all our other rights. This means you may not sell, rewrite, or modify any content or other material found on any Clinical Education Alliance Site, redistribute it, put it on your own Web site, or use it for any commercial purpose without our prior written authorization.

The names of the CEA products and services are protected by trademark laws in the United States. Any use of our trademarks or service marks requires prior written approval from CEA.

You may link to a CEA Web site if your Web site offers products, services, or information of interest to the professional healthcare community. You are not allowed to link to the Clinical Education Alliance Sites if you post illegal, obscene, or offensive content or if the link is likely to have a negative impact on CEA’s reputation. Any other use, such as framing any part of a CEA Web site or incorporating any CEA content into another Web site, product, or application, requires advance written permission from Clinical Education Alliance. Clinical Education Alliance assumes no responsibility for any Web sites or materials that are linked to Clinical Education Alliance Sites or materials.

Software Products and Applications

Clinical Education Alliance makes some software and accompanying documentation available for downloading from our Web sites and/or from iTunes. These materials are protected by copyrights under US and international law and are owned by Clinical Education Alliance or companies that have licensed the software to us. We do not transfer any ownership rights in software or documentation to you when you download it from our Web site and/or directly from iTunes. You may use the software and accompanying documentation for their intended purpose. You are not authorized to further copy or distribute the software and accompanying documentation, nor may you attempt to recreate or reverse engineer our software or applications. In addition, some software available for downloading from our Web sites and/or from iTunes is subject to US export controls. By downloading or using such software, you are representing to us that your download of such software complies with these controls.

US Government End Users

If you are affiliated with the US government, please note that the software and documentation available on our Web sites and/or directly from iTunes are “commercial items,” as that term is defined in 48 C.F.R. 2.101 (October 1995), consisting of “commercial computer software” and “commercial computer software documentation,” as such terms are used in 48 C.F.R. 12.212 (September 1995). Consistent with 48 C.F.R. 12.212 and 48 C.F.R. 227.7202-1 through 227.7202-4 (June 1995), all US government end users acquire the software and documentation with only those rights set forth herein.

Social Media, Message Boards, and Forums

Clinical Education Alliance offers users the opportunity to engage in social media interactions with both experts and other users of the sites. As with other online social media, users must exercise sound judgment in both the information that they post and in how they assess the postings of other users. As such, users are expected to adhere to the social media recommendations made by the American Medical Association when utilizing the social media capabilities of CEA sites. In particular, users must be cognizant of standards of patient privacy and confidentiality that must be maintained in all environments and must not post identifiable patient information on CEA sites. In social media interactions, users must maintain appropriate boundaries of the patient–physician/care provider relationship in accordance with professional ethical guidelines just as they would in any other context. Users acknowledge that privacy settings are not absolute and that once on the Internet, content posted by them may be copied by third parties and republished out of the control of Clinical Education Alliance. Thus, users should routinely monitor their own Internet presence to ensure that the personal information and content that they post and, to the extent possible, that is posted about them by others is accurate and appropriate.

Users are expected to refrain from submitting comments or messages that are defamatory, hateful, or obscene or that harass others. Users may not impersonate any other person or violate any other person’s or entity’s legal rights or submit falsified credentials or experiences. Users agree that they will not submit any materials that violate or infringe any copyrights, trademarks, patents, trade secret, or other intellectual property rights of any third party. Clinical Education Alliance retains all copyrights in the content posted by users to its sites. Clinical Education Alliance may adopt additional rules to govern use of social media, message boards or forums, to which users will be subject.

Copyright and Other Legal Violations

If you believe that any material on this Web site infringes your copyright, please notify us as follows, under the Digital Millennium Copyright Act (“DMCA”). To notify us, the DMCA requires that you: 1. Send an email notice to Clinical Education Alliance at customersupport@clinicaloptions.com. 2. Include the following information in your email: a. Identify the copyrighted work(s) you claim is infringed; b. Identify the material you claim is infringing the copyright(s) and give enough information for Clinical Education Alliance to locate that material; c. Include a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf (the “Claimant”); d. Include the Claimant’s name, address, and telephone number(s); e. Include a statement that the Claimant has a good faith belief that use of the disputed material is not authorized by the copyright owner or his agent; and f. Include a statement, under penalty of perjury, that the information in the notification of copyright infringement is accurate and that the Claimant is the copyright owner or is authorized to act on behalf of the copyright owner.

If you believe any content or material on the Clinical Education Alliance Sites violates any laws, please notify customersupport@clinicaloptions.com. Please include details about your concerns and an email address for contacting you.

Governing Law

Clinical Education Alliance controls the Clinical Education Alliance Sites from its offices in the state of Virginia in the United States of America. The Clinical Education Alliance Sites can be accessed from any of the United States and from other countries worldwide. Since the laws of each state or country may differ, both you and Clinical Education Alliance agree that the laws of Virginia, without regard to conflicts of laws principles, will apply to all matters relating to use of the Clinical Education Alliance Sites and materials, including software and applications.

Clinical Education Alliance makes no representation that materials on these sites are appropriate or available for use in countries aside from the United States. Accessing the Clinical Education Alliance Sites from territories where their contents are illegal is prohibited. Those who choose to access these sites from other locations do so at their own risk and are responsible for compliance with any and all applicable local laws or regulations.

Acceptance Procedure

By downloading or accessing materials on the Clinical Education Alliance Sites and/or directly from iTunes or registering with us, you agree to all the terms and conditions in this agreement, including the Terms of Use and Privacy Policy. If you disagree with any of these Terms of Use or Privacy Policy, please refrain from using the Clinical Education Alliance Sites or materials.

Privacy Policy

Because we provide education for healthcare professionals, we pay special attention to privacy issues. The purpose of our Privacy Policy is to identify the information we may collect about you, describe the uses we may make of your information and the security measures we take to protect it, and discuss your options for controlling your information. You can review our Privacy Policy by clicking on the “Privacy Policy” link at the bottom of designated pages on the Clinical Education Alliance Sites.

Disputes

If you fail to comply with these terms, we have the right to suspend or eliminate your account and remove any information you have placed on our site, including your registration information. We may also take any legal action we think is appropriate. If there is any dispute between us concerning this agreement or your use of any Clinical Education Alliance Site or materials or applications, we both agree to submit the dispute to nonbinding mediation, followed by binding arbitration. Both the mediation and the arbitration will be governed under the rules of the American Arbitration Association, and the venue for the arbitration will be Virginia.

Questions or Concerns About Our Terms of Use

For questions or concerns about these Terms of Use, please send an email to customersupport@clinicaloptions.com

These terms of use were last updated in July 2021.

9th Annual Psychopharmacology Update 2023

Who Should Attend

Time and location